Smoking, Death, and Alzheimer Disease
- 1 October 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Alzheimer Disease & Associated Disorders
- Vol. 26 (4), 300-306
- https://doi.org/10.1097/wad.0b013e3182420b6e
Abstract
If smoking is a risk factor for Alzheimer disease (AD) but a smoker dies of another cause before developing or manifesting AD, smoking-related mortality may mask the relationship between smoking and AD. This phenomenon, referred to as competing risk, complicates efforts to model the effect of smoking on AD. Typical survival regression models assume that censorship from analysis is unrelated to an individual’s probability for developing AD (ie, censoring is noninformative). However, if individuals who die before developing AD are younger than those who survive long enough to develop AD, and if they include a higher percentage of smokers than nonsmokers, the incidence of AD will appear to be higher in older individuals and in nonsmokers. Further, age-specific mortality rates are higher in smokers because they die earlier than nonsmokers. Therefore, if we fail to take into account the competing risk of death when we estimate the effect of smoking on AD, we bias the results and are in fact only comparing the incidence of AD in nonsmokers with that in the healthiest smokers. In this study, we demonstrate that the effect of smoking on AD differs in models that are and are not adjusted for competing risks.Keywords
This publication has 37 references indexed in Scilit:
- The Risk of Incident Coronary Heart Disease Among Veterans With and Without HIV and Hepatitis CCirculation: Cardiovascular Quality and Outcomes, 2011
- The challenge of publishing newsworthy epidemiologyAnnals of Neurology, 2010
- Secondhand Smoke, Vascular Disease, and Dementia Incidence: Findings From the Cardiovascular Health Cognition StudyAmerican Journal of Epidemiology, 2010
- Lost in TranslationArchives of Neurology, 2010
- Cigarette Smoking and DementiaEpidemiology, 2008
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A CASE-CONTROL STUDY OF SMOKING AND ALZHEIMER'S DISEASEInternational Journal of Geriatric Psychiatry, 1997
- THE “PROTECTIVE” INFLUENCE OF CIGARETTE SMOKING ON ALZHEIMER'S AND PARKINSON'S DISEASES: Quagmire or Opportunity for Neuroepidemiology?Neurologic Clinics, 1996
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982